Voloridge Investment Management
IART icon

Voloridge Investment Management’s Integra LifeSciences IART Stock Holding History

Voloridge Investment Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Sell
79,689
-173,215
-68% -$2.42M 0.01% 682
2026
Q1 		$2.38M Sell
252,904
-180,484
-42% -$1.98M 0.01% 803
2025
Q4 		$5.38M Sell
433,388
-60,570
-12% -$805K 0.02% 748
2025
Q3 		$7.08M Sell
493,958
-255,830
-34% -$3.5M 0.02% 641
2025
Q2 		$9.2M Buy
749,788
+165,219
+28% +$2.4M 0.03% 570
2025
Q1 		$12.9M Sell
584,569
-144,847
-20% -$3.41M 0.05% 488
2024
Q4 		$16.5M Sell
729,416
-329,710
-31% -$7.2M 0.06% 409
2024
Q3 		$19.2M Buy
1,059,126
+231,270
+28% +$5.36M 0.07% 385
2024
Q2 		$24.1M Buy
827,856
+256,536
+45% +$7.61M 0.09% 309
2024
Q1 		$20.3M Buy
571,320
+260,992
+84% +$10.4M 0.07% 332
2023
Q4 		$13.5M Buy
310,328
+33,935
+12% +$1.34M 0.05% 403
2023
Q3 		$10.6M Buy
276,393
+8,488
+3% +$357K 0.05% 453
2023
Q2 		$11M Buy
267,905
+168,751
+170% +$8.12M 0.05% 435
2023
Q1 		$5.69M Sell
99,154
-53,835
-35% -$3.03M 0.03% 634
2022
Q4 		$8.58M Sell
152,989
-66,807
-30% -$3.4M 0.05% 472
2022
Q3 		$9.31M Buy
219,796
+86,663
+65% +$4.44M 0.05% 462
2022
Q2 		$7.19M Buy
133,133
+42,045
+46% +$2.53M 0.04% 549
2022
Q1 		$5.85M Buy
+91,088
New +$6M 0.03% 588
2021
Q2 		– Sell
-3,677
Closed -$254K – 1684
2021
Q1 		$254K Sell
3,677
-81,981
-96% -$5.55M ﹤0.01% 1278
2020
Q4 		$5.56M Sell
85,658
-39,201
-31% -$2.11M 0.05% 427
2020
Q3 		$5.9M Buy
124,859
+105,714
+552% +$5.03M 0.05% 405
2020
Q2 		$900K Sell
19,145
-15,429
-45% -$758K 0.01% 887
2020
Q1 		$1.54M Sell
34,574
-3,913
-10% -$205K 0.04% 416
2019
Q4 		$2.24M Buy
+38,487
New +$2.29M 0.04% 466

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Voloridge Investment Management's IART Position: Q2 2026 in Review

Voloridge Investment Management reduced its Integra LifeSciences (IART) stake by 68% in Q2 2026, selling an estimated $2.42M and leaving 79,689 shares worth $1.43M. The position accounts for 0.01% of the portfolio, ranked #682.

Voloridge Investment Management first reported a position in IART in Q4 2019 and has held it in 24 quarters since. The position peaked at $24.1M in Q2 2024. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Voloridge Investment Management held 79,689 shares of Integra LifeSciences worth $1.43M as of Q2 2026.
  • Voloridge Investment Management sold 173,215 Integra LifeSciences shares in Q2 2026, an estimated $2.42M.
  • Integra LifeSciences made up 0.01% of Voloridge Investment Management's portfolio in Q2 2026, its #682 holding.
  • Voloridge Investment Management first reported a position in Integra LifeSciences in Q4 2019 and has held it in 24 quarters since.
  • Voloridge Investment Management's Integra LifeSciences position peaked at $24.1M in Q2 2024.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.